Details for 2017837917

Up to date per 02.04.2026

Actions

Title / Product Name

AKTIVIERBARE ANTI-CTLA-4-ANTIKÖRPER UND VERWENDUNGEN DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017837917

EP Publication Number

3535300

E-Number

1849078

Language

PCT Number

US17059740

Publication Date

11.09.2019 A

22.10.2025 B1

Registration Date

22.10.2025

AT Publication Date

15.11.2025

Application Date

02.11.2017

Registration Number

Priorities

03.11.2016

201662417212 P

IPC

C07K 16/28 20060101AFI20250501BHEP

Maximum Duration of Protection

02.11.2037

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

CytomX Therapeutics, Inc.151 Oyster Point Boulevard Suite 400 South San Francisco, California 94080US

Representative

No representatives present

Inventor

TIPTON, Kimberly Annc/o CytomX Therapeutics Inc. 151 Oyster Point Boulevard Suite 400 South San Francisco, California 94080US

WEST, James Williamc/o CytomX Therapeutics Inc. 151 Oyster Point Boulevard, Suite 400 South San Francisco, California 94080US

DESHPANDE, Shrikantc/o Bristol-Myers Squibb Company 700 Bay Road Redwood City, California 94063US

ENGELHARDT, John J.c/o Bristol-Myers Squibb Company 700 Bay Road Redwood City, California 94063US